Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients

2000 ◽  
Vol 42 (9) ◽  
pp. 692-696 ◽  
Author(s):  
F. Gelbert ◽  
O. Enjolras ◽  
D. Deffrenne ◽  
A. Aymard ◽  
C. Mounayer ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Venous Malformation ◽  
Percutaneous Sclerotherapy

Percutaneous sclerotherapy for spongiform venous malformations – analysis of patient-evaluated outcome and satisfaction

VASA ◽  
2017 ◽  
Vol 46 (6) ◽  
pp. 477-483
Author(s):  
Robert Karl Clemens ◽  
Frederic Baumann ◽  
Marc Husmann ◽  
Thomas Oleg Meier ◽  
Christoph Thalhammer ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Medical Records ◽  
Venous Malformation ◽  
Primary Treatment ◽  
Venous Malformations ◽  
Treated Area ◽  
Item Questionnaire ◽  
Percutaneous Sclerotherapy ◽  
Multiple Treatments ◽  
Pain Improvement

Abstract. Background: Congenital venous malformations are frequently treated with sclerotherapy. Primary treatment goal is to control the often size-related symptoms. Functional impairment and aesthetical aspects as well as satisfaction have rarely been evaluated. Patients and methods: Medical records of patients who underwent sclerotherapy of spongiform venous malformations were reviewed and included in this retrospective study. The outcome of sclerotherapy as self-reported by patients was assessed in a 21 item questionnaire. Results: Questionnaires were sent to 166 patients with a total of 327 procedures. Seventy-seven patients (48 %) with a total of 159 procedures (50 %) responded to the survey. Fifty-seven percent of patients were male. The age ranged from 1 to 38.1 years with a median age of 16.4 years. The lower extremities were the most common treated area. Limitations caused by the venous malformation improved in the majority of patients (e.g. pain improvement 87 %, improvement of swelling 83 %) but also worsening of symptoms occurred in a minority of cases. Seventy-seven per cent would undergo sclerotherapy again. Conclusions: Sclerotherapy for treatment of venous malformations results in significant reduction of symptoms. Multiple treatments are often needed, but patients are willing to undergo them.

scholarly journals A case of spinal epidural venous malformation with mediastinal extension: management with combined surgery and percutaneous sclerotherapy

2016 ◽  
Vol 17 (5) ◽  
pp. 612-617 ◽  
Author(s):  
Gurpreet S. Gandhoke ◽  
Sabri Yilmaz ◽  
Lorelei Grunwaldt ◽  
Ronald L. Hamilton ◽  
David J. Salvetti ◽  
...  
Keyword(s):  
Venous Malformation ◽  
Dorsal Column ◽  
Venous Hypertension ◽  
Neurogenic Claudication ◽  
Subtotal Resection ◽  
Migraine Headaches ◽  
Postoperative Mri ◽  
Percutaneous Sclerotherapy ◽  
Mri Study ◽  
Spinal Epidural

While spinal epidural arteriovenous malformations, fistulas, and shunts are well reported, the presence of a venous malformation in the spinal epidural space is a rare phenomenon. Herein, the authors report the clinical presentation, imaging findings, pathological features, and the outcome of surgical and percutaneous interventional management of a mediastinal and spinal epidural venous malformation in a young woman who presented clinically with neurogenic claudication from presumed venous hypertension precipitating the formation of a syrinx. The patient underwent a C6–T5 osteoplastic laminectomy for decompression of the spinal canal and subtotal resection of the epidural venous malformation, followed by percutaneous sclerotherapy of the mediastinal and residual anterior spinal venous malformation. She developed transient loss of dorsal column sensation, which returned to baseline within 3 weeks of the surgery. A 6-month postoperative MRI study revealed complete resolution of the syrinx and the mediastinal venous malformation. Twelve months after the surgery, the patient has had resolution of all neurological symptoms with the exception of her premorbid migraine headaches. A multidisciplinary approach with partial resection and the use of percutaneous sclerotherapy for the residual malformation can be used to successfully treat a complex venous malformation.

scholarly journals Predictive Factors for Successful Percutaneous Sclerotherapy of Venous and Lymphatic Malformations

2013 ◽  
Vol 19 (1) ◽  
pp. 29-42
Author(s):  
Anchalee Churojana ◽  
Laksanawadee Mahiwan ◽  
Dittapong Songsaeng ◽  
Rujimas Khumtong ◽  
Saowanee Homsud
Keyword(s):  
Treatment Outcome ◽  
Predictive Factors ◽  
Venous Malformation ◽  
Treatment Result ◽  
Focal Lesions ◽  
Lymphatic Malformations ◽  
Sclerosing Agents ◽  
Percutaneous Sclerotherapy ◽  
Good Treatment Outcome ◽  
Sclerosing Therapy

Objectives: To determine the predictive factors for good response outcome of venous (VMs) and lymphatic malformations (LMs) by percutaneous sclerosing therapy and to compare the complications associated with bleomycin versus alcohol treatment. Methods: A retrospective analysis of 225 patients with lymphatic and venous malformation who had treated by percutaneous sclerotherapy using alcohol and/or bleomycin was performed The treatment outcome was graded from 0-3, in orderly of clinical responsiveness by using visual assessment of changing in size and subjective improvement of symptoms. Predictive factors of good treatment outcome were determined by uni- and multivariate analysis which were conducted on sex, age, onset of disease, location, type, characteristic of lesion and sclerosant usage. Results: Of 225 patients, 87.6% were VMs and 12.4% were LMs. VMs were predominating in female (6.2:3.8). Between ethanol and bleomycin, there was no statistical significant of treatment sessions, dose and treatment outcome. (p= .42) Sclerosing therapy provided better response on VMs than LMs. (49.2% and 21.4% respectively, p=.002), and had more effective on focal lesions than diffuse patterns (64.9% and 26.1% respectively p<.001) The gender, onset of disease, locations, characteristic on venography and preceding treatment showed no correlation with treatment result. Major complications of ethanol occurred in 38.6%,including hematuria, gangrene, facial paralysis, pulmonary embolism and death. Minor adverse reactions of bleomycin encountered in 19.8% with hyperpigmentation, flu-like symptom and localized fibrosis. Conclusion: Both absolute alcohol and bleomycin were effective sclerosing agents for percutaneous treatment of venous malformations, but no serious complications encountered with bleomycin. The characteristic of focal single lesion, at any region of body part, can be a predictor for good response.

scholarly journals Combined percutaneous sclerotherapy and plastic surgery for the treatment of lower lip venous malformation

2019 ◽  
Vol 48 ◽  
pp. 101271
Author(s):  
Tran Thanh Vy ◽  
Lam Thao Cuong ◽  
Ho Tat Bang ◽  
Tran Quyet Tien
Keyword(s):  
Plastic Surgery ◽  
Venous Malformation ◽  
Lower Lip ◽  
Percutaneous Sclerotherapy

The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center

2016 ◽  
Vol 31 (9) ◽  
pp. 603-609 ◽  
Author(s):  
Sumera Ali ◽  
Clifford R Weiss ◽  
Amitasha Sinha ◽  
John Eng ◽  
Sally E Mitchell
Keyword(s):  
Medical Center ◽  
Venous Malformation ◽  
Academic Medical Center ◽  
Clinical Manifestations ◽  
Final Analysis ◽  
Therapeutic Effects ◽  
Vein Thrombosis ◽  
Common Location ◽  
Percutaneous Sclerotherapy ◽  
Procedural Complications

Purpose We report a retrospective analysis of venous malformation patients treated with percutaneous sclerotherapy, describing their clinical manifestations, therapeutic outcomes and procedural complications. Materials and methods We reviewed our Vascular Anomalies database for all patients who underwent percutaneous sclerotherapy for venous malformation between January 2005 and July 2011 and retrieved 186 patients, out of which 116 were included in the final analysis. The majority of patients were treated using 100% alcohol (72%) and the rest were treated with <100% alcohol, Sodium Tetradecyl Sulfate or combination of these therapies. The most common location was the lower extremity in 67 patients (58%), followed by the head and neck in 27 (23%) and the upper extremity in 11 (9%). Retrospective review of medical records was performed. Outcomes were classified on an improvement scale based on clinical therapeutic effects. Results Two-hundred and forty-five sclerotherapy procedures were performed in 116 patients, of which 52 patients (45%) underwent a single procedure, 32 (28%) had two procedures and 32 (28%) underwent ≥3 procedures. Median follow-up period from the last procedure was 2.5 months (interquartile range of 2.0 to 6.75 months). Significant improvement was seen in 37 patients (32%), moderate improvement in 31 (27%), mild improvement in 20 (17%), no improvement in 21 (18%) and worse than before in 7 (6%) patients. Major post-procedural complications were nerve injuries in 6 patients (5%), deep vein thrombosis in 5 (4%), muscle contracture in 2 (2%), infection in 3 (3%), skin necrosis in 4 (3%) and other complications in 3 (3%). Conclusion Our study demonstrated that 76% of our patients with venous malformation had some level of improvement in symptoms with majority (72%) undergoing only one or two percutaneous sclerotherapy procedure/s. Although major complications occurred in 20% of the patients, majority (74%) of the complications either resolved spontaneously or were successfully treated.

Operative management of equinus associated with lower limb venous malformations

2021 ◽  
pp. 026835552110472
Author(s):  
Li Hu ◽  
Hui Chen ◽  
Xi Yang ◽  
Yi Sun ◽  
Hongyuan Liu ◽  
...  
Keyword(s):  
Lower Limb ◽  
Clinical Symptoms ◽  
Venous Malformation ◽  
Operative Management ◽  
Venous Malformations ◽  
Optimal Outcomes ◽  
Percutaneous Sclerotherapy ◽  
Experienced Pain ◽  
Male Patients

Objectives Functional impairment is a common complaint in patients with venous malformations. Equinus can occur when the venous malformation involves the lower limb, a challenging condition with only a few studies to guide treatment choices. This study was aimed to investigate the operative management of equinus associated with lower limb venous malformations. Method Between August 2015 and September 2017, a total of 12 patients presented with equinus associated with lower limb venous malformations and underwent surgical correction. Preoperative and postoperative clinical symptoms, physical examination and orthopaedic evaluation were retrospectively reviewed. 8 patients who experienced pain underwent percutaneous sclerotherapy prior to the operation. Surgical management included gastrocnemius intramuscular aponeurotic recession, Z-lengthening of the Achilles tendon, Hoke technique and Taylor Spatial Frame external fixation. Results There were eight female and four male patients with a mean age of 14.3 ± 5.9 years. The mean follow-up period was 34.8 ± 9 months. The range of motion of ankle dorsiflexion (with knee extended) improved for each patient (mean, 25.4 degrees; standard deviation, 8.5 degrees). No neurovascular complications were observed. Conclusion Operative correction of equinus associated with lower limb venous malformations is safe and effective. Selective preoperative sclerotherapy is necessary for optimal outcomes.

Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series

2018 ◽  
Vol 34 (5) ◽  
pp. 355-361 ◽  
Author(s):  
Saima Ahmad ◽  
Fahd Kamal Akhtar
Keyword(s):  
Venous Malformation ◽  
Symptomatic Relief ◽  
Case Series ◽  
Uneventful Recovery ◽  
Venous Malformations ◽  
Sclerosing Agents ◽  
Percutaneous Sclerotherapy ◽  
Angiography Suite ◽  
Orbital Region

Purpose To present a case series of percutaneous sclerotherapy of para-orbital and orbital venous malformations. Method Seven patients with venous malformations in the orbital and para-orbital region were reviewed. Puncture venogram was performed on all patients and image guided bleomycin injections using biplane digital subtraction in angiography suite. Results Average age of patients at the time of the procedure was 22 years old with the youngest being five years of age and the oldest being 50 years. Follow-ups ranged from 3 months to 18 months and the average follow-up duration was 13 months. The patients had no intraprocedural complications and reported symptomatic relief of pain as per the last follow-up. Patients have shown no symptoms or signs of recurrence of lesions with uneventful recovery so far. Conclusions Percutaneous sclerotherapy of orbital Venous Malformations with bleomycin is a safe and well-controlled procedure done in real time; it has no major systemic adverse side effects and higher efficacy than other sclerosing agents.

Sign in / Sign up

Export Citation Format

Share Document